6 Quick Takeaways From This Year’s JP Morgan Healthcare Conference

By Adam Goulburn, PhD

1. Early stage investors are wary — it feels like most have pressed pause and are in hold mode

2. Genomics momentum — liquid biopsies are hot with most thinking that we’re just scratching the surface of clinical and consumer genomics

3. Digital health continues to infiltrate the conference — no longer just about biotech. After all it is the JPM healthcare conference but…

4. No breakout, dominant, oft-spoken about companies — digital health lost a little of it’s lustre. Last year we had companies like Teladoc, Fitbit, Health Catalyst on the verge, this year it seemed to be lacking

5. Providers are still trying to figure out the innovation thing — with the EMR plumbing complete and doctors now online, large systems are trying to figure out what they can do on top and how to make the data liquid

6. Door list exclusivity! — reinforce your relationships for next year, some of the evening networking events are getting tougher to get into than a Vegas nightclub!